“Rising Incidence of Hepatocellular Carcinoma linked to Metabolic Dysfunction-Associated Fatty Liver Disease: Challenges and Countermeasures”

https://pubmed.ncbi.nlm.nih.gov/38115921

The abstract discusses the rising incidence of hepatocellular carcinoma related to metabolic dysfunction-associated fatty liver disease, and highlights the challenges and potential countermeasures in managing this condition.